AMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Amgen Inc's quarterly accounts payable declined from Dec. 2014 ($6,508 Mil) to Mar. 2015 ($5,836 Mil) and declined from Mar. 2015 ($5,836 Mil) to Jun. 2015 ($5,641 Mil).
Amgen Inc's annual accounts payable declined from Dec. 2012 ($5,696 Mil) to Dec. 2013 ($5,442 Mil) but then increased from Dec. 2013 ($5,442 Mil) to Dec. 2014 ($6,508 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Amgen Inc Annual Data
Amgen Inc Quarterly Data